These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24578825)

  • 1. Clinical utility of serum sclerostin measurements.
    Clarke BL; Drake MT
    Bonekey Rep; 2013; 2():361. PubMed ID: 24578825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal and systemic regulation of sclerostin.
    Drake MT; Khosla S
    Bone; 2017 Mar; 96():8-17. PubMed ID: 27965160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus.
    Gaudio A; Privitera F; Battaglia K; Torrisi V; Sidoti MH; Pulvirenti I; Canzonieri E; Tringali G; Fiore CE
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3744-50. PubMed ID: 22855334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study.
    Garnero P; Sornay-Rendu E; Munoz F; Borel O; Chapurlat RD
    Osteoporos Int; 2013 Feb; 24(2):489-94. PubMed ID: 22525978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periostin and sclerostin levels in individuals with spinal cord injury and their relationship with bone mass, bone turnover, fracture and osteoporosis status.
    Maïmoun L; Ben Bouallègue F; Gelis A; Aouinti S; Mura T; Philibert P; Souberbielle JC; Piketty M; Garnero P; Mariano-Goulart D; Fattal C
    Bone; 2019 Oct; 127():612-619. PubMed ID: 31351195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sclerostin, Osteocytes, and Chronic Kidney Disease - Mineral Bone Disorder.
    Moysés RM; Schiavi SC
    Semin Dial; 2015; 28(6):578-86. PubMed ID: 26288182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased Circulating Sclerostin Levels in Renal Transplant Recipients With Persistent Hyperparathyroidism.
    Evenepoel P; Claes K; Viaene L; Bammens B; Meijers B; Naesens M; Sprangers B; Kuypers D
    Transplantation; 2016 Oct; 100(10):2188-93. PubMed ID: 27379556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise Alleviates Osteoporosis in Rats with Mild Chronic Kidney Disease by Decreasing Sclerostin Production.
    Liao HW; Huang TH; Chang YH; Liou HH; Chou YH; Sue YM; Hung PH; Chang YT; Ho PC; Tsai KJ
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31027235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with serum soluble inhibitors of Wnt-β-catenin signaling (sclerostin and dickkopf-1) in patients undergoing peritoneal dialysis.
    Yamada S; Tsuruya K; Tokumoto M; Yoshida H; Ooboshi H; Kitazono T
    Nephrology (Carlton); 2015 Sep; 20(9):639-45. PubMed ID: 25974190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship Between Osteoporosis and Serum Sclerostin Levels in Kidney Transplant Recipients.
    Basir H; Altunoren O; Erken E; Kilinc M; Sarisik FN; Isiktas S; Gungor O
    Exp Clin Transplant; 2024 Jul; 22(7):514-521. PubMed ID: 31526333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma.
    McDonald MM; Reagan MR; Youlten SE; Mohanty ST; Seckinger A; Terry RL; Pettitt JA; Simic MK; Cheng TL; Morse A; Le LMT; Abi-Hanna D; Kramer I; Falank C; Fairfield H; Ghobrial IM; Baldock PA; Little DG; Kneissel M; Vanderkerken K; Bassett JHD; Williams GR; Oyajobi BO; Hose D; Phan TG; Croucher PI
    Blood; 2017 Jun; 129(26):3452-3464. PubMed ID: 28515094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a novel, rapid, high precision sclerostin assay not confounded by sclerostin fragments.
    Drake MT; Fenske JS; Blocki FA; Zierold C; Appelman-Dijkstra N; Papapoulos S; Khosla S
    Bone; 2018 Jun; 111():36-43. PubMed ID: 29550267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated serum sclerostin level in the T2DM patients with femur fracture inhibits the expression of bone formation/remodeling-associated biomarkers via antagonizing Wnt signaling.
    Wu Y; Xu SY; Liu SY; Xu L; Deng SY; He YB; Xian SC; Liu YH; Ni GX
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):470-478. PubMed ID: 28239825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of bone SOST, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women.
    Reppe S; Noer A; Grimholt RM; Halldórsson BV; Medina-Gomez C; Gautvik VT; Olstad OK; Berg JP; Datta H; Estrada K; Hofman A; Uitterlinden AG; Rivadeneira F; Lyle R; Collas P; Gautvik KM
    J Bone Miner Res; 2015 Feb; 30(2):249-56. PubMed ID: 25155887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sclerostin: Intracellular mechanisms of action and its role in the pathogenesis of skeletal and vascular disorders.
    Pietrzyk B; Smertka M; Chudek J
    Adv Clin Exp Med; 2017 Nov; 26(8):1283-1291. PubMed ID: 29264888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum extracellular secreted antagonists of the canonical Wnt/β-catenin signaling pathway in patients with Cushing's syndrome.
    Belaya ZE; Rozhinskaya LY; Melnichenko GA; Solodovnikov AG; Dragunova NV; Iljin AV; Dzeranova LK; Dedov II
    Osteoporos Int; 2013 Aug; 24(8):2191-9. PubMed ID: 23358608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis.
    Rossini M; Viapiana O; Idolazzi L; Ghellere F; Fracassi E; Troplini S; Povino MR; Kunnathully V; Adami S; Gatti D
    Calcif Tissue Int; 2016 May; 98(5):438-45. PubMed ID: 26645432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in sclerostin and clinical characteristics in type 1 diabetes mellitus.
    Catalano A; Pintaudi B; Morabito N; Di Vieste G; Giunta L; Bruno ML; Cucinotta D; Lasco A; Di Benedetto A
    Eur J Endocrinol; 2014 Sep; 171(3):293-300. PubMed ID: 24891138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum sclerostin levels are positively related to bone mineral density in peritoneal dialysis patients: a cross-sectional study.
    Kuo TH; Lin WH; Chao JY; Wu AB; Tseng CC; Chang YT; Liou HH; Wang MC
    BMC Nephrol; 2019 Jul; 20(1):266. PubMed ID: 31315601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD.
    Behets GJ; Viaene L; Meijers B; Blocki F; Brandenburg VM; Verhulst A; D'Haese PC; Evenepoel P
    PLoS One; 2017; 12(5):e0176411. PubMed ID: 28493902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.